Biodesix (BDSX) Net Income towards Common Stockholders Growth (3y) (2022 - 2026)
Biodesix (BDSX) Net Income towards Common Stockholders Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.22% |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | 49.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.15% |
| Dec 31, 2025 | 24.56% |
| Sep 30, 2025 | 11.99% |
| Jun 30, 2025 | -8.88% |
| Mar 31, 2025 | 13.99% |
| Dec 31, 2024 | 6.70% |
| Sep 30, 2024 | 24.19% |
| Jun 30, 2024 | 31.32% |
| Mar 31, 2024 | 32.08% |
| Dec 31, 2023 | -61.99% |
| Sep 30, 2023 | -11.28% |
| Jun 30, 2023 | -59.14% |
| Mar 31, 2023 | -87.03% |
| Dec 31, 2022 | -41.09% |
| Sep 30, 2022 | -52.86% |